Výsledky vyhledávání

Pembrolizumab for the better treatment of EGFR-mutant T790M-negative advanced lung adenocarcinoma patients than dual treatment of pemetrexed plus platinum after tyrosine kinase inhibitor treatment failure

Autor: Zhuming, Lu, Ming, Ye, Tao, Sun, Suoyun, Wu, Zhichao, Lin, Xin, Zhang, Dongping, Rao, Dongxi, Zhang, Yongwen, Ke, Zhuowen, Chen

Publikováno v: Annals of Palliative Medicine. 11:2100-2109

The treatment of lung cancer patients, especially those with epidermal growth factor receptor (EGFR)-mutant T790M-negative adenocarcinoma, after first- or second-line tyrosine kinase inhibitor (TKI) treatment failure is challenging due to the poor pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f9ac5947a073a7be335b42bb661957
https://doi.org/10.21037/apm-22-671

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání